M-CSF	JJ	B-NP	O	Other	No	No	Other	Other	###	1	M-CSF	M-CSF	JJ	JJ	_	4	amod	_	_
-	-	O	O	Other	No	No	Other	Other	###	2	-	-	-	-	_	4	punct	_	_
Dependent	JJ	B-NP	O	Other	No	No	Other	Other	###	3	Dependent	Dependent	JJ	JJ	_	4	amod	_	_
Activation	NN	I-NP	O	Other	No	No	Other	Other	###	4	Activation	Activation	NN	NN	_	9	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	5	of	of	IN	IN	_	6	case	_	_
PKC	NN	B-NP	B-protein	Other	No	No	Other	Other	###	6	PKC	PKC	NN	NN	_	4	nmod	_	_
Does	VBZ	B-VP	O	Other	No	No	Other	Other	###	7	Does	Does	VBZ	VBZ	_	9	aux	_	_
Not	RB	I-VP	O	Other	No	No	Other	Other	###	8	Not	Not	RB	RB	_	9	neg	_	_
Regulate	VB	I-VP	O	Other	No	No	Other	B-Regulation	###	9	Regulate	Regulate	VB	VB	_	0	root	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	10	the	the	DT	DT	_	15	det	_	_
Classical	JJ	I-NP	O	Other	No	No	Other	Other	###	11	Classical	Classical	JJ	JJ	_	15	amod	_	_
NF-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	12	NF-kappaB	NF-kappaB	NN	NN	_	15	compound	_	_
p65	NN	I-NP	I-protein	B-Protein	No	No	B-Protein	Other	###	13	p65	p65	NN	NN	_	15	compound	_	_
Activation	NN	I-NP	O	Other	No	No	Other	B-Positive_regulation	###	14	Activation	Activation	NN	NN	_	15	compound	_	_
Pathway	NN	I-NP	O	Other	No	No	Other	Other	###	15	Pathway	Pathway	NN	NN	_	9	dobj	_	_

Canonical	JJ	B-NP	O	Other	No	No	Other	Other	###	1	Canonical	Canonical	JJ	JJ	_	2	amod	_	_
activation	NN	I-NP	O	Other	No	No	Other	Other	###	2	activation	activation	NN	NN	_	5	nsubj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	3	of	of	IN	IN	_	4	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	4	NF-kappaB	NF-kappaB	NN	NN	_	2	nmod	_	_
occurs	VBZ	B-VP	O	Other	No	No	Other	Other	###	5	occurs	occurs	VBZ	VBZ	_	0	root	_	_
via	IN	B-PP	O	Other	No	No	Other	Other	###	6	via	via	IN	IN	_	7	case	_	_
phosphorylation	NN	B-NP	O	Other	No	No	Other	B-Phosphorylation	###	7	phosphorylation	phosphorylation	NN	NN	_	5	nmod	_	_
and	CC	I-NP	O	Other	No	No	Other	Other	###	8	and	and	CC	CC	_	7	cc	_	_
degradation	NN	I-NP	O	Other	No	No	Other	B-Protein_catabolism	###	9	degradation	degradation	NN	NN	_	7	conj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	10	of	of	IN	IN	_	11	case	_	_
IkappaBalpha	NN	B-NP	B-protein	B-Protein	No	No	B-Protein	Other	###	11	IkappaBalpha	IkappaBalpha	NN	NN	_	7	nmod	_	_
leading	VBG	B-VP	O	Other	No	No	Other	Other	###	12	leading	leading	VBG	VBG	_	11	acl	_	_
to	TO	B-PP	O	Other	No	No	Other	Other	###	13	to	to	TO	TO	_	15	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	14	the	the	DT	DT	_	15	det	_	_
release	NN	I-NP	O	Other	No	No	Other	Other	###	15	release	release	NN	NN	_	12	nmod	_	_
and	CC	O	O	Other	No	No	Other	Other	###	16	and	and	CC	CC	_	15	cc	_	_
nuclear	JJ	B-NP	O	Other	No	No	Other	Other	###	17	nuclear	nuclear	JJ	JJ	_	18	amod	_	_
translocation	NN	I-NP	O	Other	No	No	Other	Other	###	18	translocation	translocation	NN	NN	_	15	conj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	19	of	of	IN	IN	_	25	case	_	_
the	DT	B-NP	O	Other	No	No	Other	Other	###	20	the	the	DT	DT	_	25	det	_	_
NF-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	21	NF-kappaB	NF-kappaB	NN	NN	_	25	compound	_	_
p50	NN	B-NP	B-protein	B-Protein	No	No	Other	Other	###	22	p50	p50	NN	NN	_	25	compound	_	_
/	/	O	O	Other	No	No	Other	Other	###	23	/	/	/	/	_	25	punct	_	_
p65	NN	B-NP	O	B-Protein	Yes	No	Other	Other	###	24	p65	p65	NN	NN	_	25	compound	_	_
heterodimer	NN	I-NP	I-protein	Other	No	No	Other	Other	###	25	heterodimer	heterodimer	NN	NN	_	15	nmod	_	_
to	TO	B-VP	O	Other	No	No	Other	Other	###	26	to	to	TO	TO	_	27	mark	_	_
transactivate	VB	I-VP	O	Other	No	No	Other	Other	###	27	transactivate	transactivate	VB	VB	_	15	acl	_	_
target	NN	B-NP	B-DNA	Other	No	No	Other	Other	###	28	target	target	NN	NN	_	29	compound	_	_
genes	NNS	I-NP	I-DNA	Other	No	No	Other	Other	###	29	genes	genes	NNS	NNS	_	27	dobj	_	_
[	(	O	O	Other	No	No	Other	Other	###	30	[	[	(	(	_	29	acl	_	_
37	CD	B-NP	O	Other	No	No	Other	Other	###	31	37	37	CD	CD	_	32	nummod	_	_
]	)	O	O	Other	No	No	Other	Other	###	32	]	]	)	)	_	30	xcomp	_	_
,	,	O	O	Other	No	No	Other	Other	###	33	,	,	,	,	_	34	punct	_	_
[	(	O	O	Other	No	No	Other	Other	###	34	[	[	(	(	_	30	conj	_	_
39	CD	B-NP	O	Other	No	No	Other	Other	###	35	39	39	CD	CD	_	36	nummod	_	_
]	)	O	O	Other	No	No	Other	Other	###	36	]	]	)	)	_	34	xcomp	_	_
.	.	O	O	Other	No	No	Other	Other	###	37	.	.	.	.	_	5	punct	_	_

Since	IN	B-SBAR	O	Other	No	No	Other	Other	###	1	Since	Since	IN	IN	_	6	mark	_	_
conventional	JJ	B-NP	O	Other	No	No	Other	Other	###	2	conventional	conventional	JJ	JJ	_	4	amod	_	_
PKC	NN	I-NP	B-protein	Other	No	No	Other	Other	###	3	PKC	PKC	NN	NN	_	4	compound	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	4	activity	activity	NN	NN	_	6	nsubj	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	5	was	was	VBD	VBD	_	6	cop	_	_
important	JJ	B-ADJP	O	Other	No	No	Other	Other	###	6	important	important	JJ	JJ	_	17	advcl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	7	in	in	IN	IN	_	8	mark	_	_
regulating	VBG	B-VP	O	Other	No	No	Other	Other	###	8	regulating	regulating	VBG	VBG	_	6	advcl	_	_
M-CSF	JJ	B-NP	O	Other	No	No	Other	Other	###	9	M-CSF	M-CSF	JJ	JJ	_	13	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	10	-	-	-	-	_	11	punct	_	_
induced	JJ	B-NP	O	Other	No	No	Other	Other	###	11	induced	induced	JJ	JJ	_	9	dep	_	_
NF-kappaB	NN	I-NP	B-protein	Other	No	No	Other	Other	###	12	NF-kappaB	NF-kappaB	NN	NN	_	13	compound	_	_
activation	NN	I-NP	O	Other	No	No	Other	Other	###	13	activation	activation	NN	NN	_	8	dobj	_	_
,	,	O	O	Other	No	No	Other	Other	###	14	,	,	,	,	_	17	punct	_	_
we	PRP	B-NP	O	Other	No	No	Other	Other	###	15	we	we	PRP	PRP	_	17	nsubj	_	_
next	RB	B-ADVP	O	Other	No	No	Other	Other	###	16	next	next	RB	RB	_	17	advmod	_	_
investigated	VBD	B-VP	O	Other	No	No	Other	Other	###	17	investigated	investigated	VBD	VBD	_	0	root	_	_
whether	IN	B-SBAR	O	Other	No	No	Other	Other	###	18	whether	whether	IN	IN	_	22	mark	_	_
IkappaBalpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	19	IkappaBalpha	IkappaBalpha	NN	NN	_	20	compound	_	_
degradation	NN	I-NP	O	Other	No	Yes	Other	B-Protein_catabolism	###	20	degradation	degradation	NN	NN	_	22	nsubjpass	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	21	was	was	VBD	VBD	_	22	auxpass	_	_
regulated	VBN	I-VP	O	Other	No	No	Other	B-Regulation	###	22	regulated	regulated	VBN	VBN	_	17	ccomp	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	23	by	by	IN	IN	_	24	case	_	_
PKC	NN	B-NP	B-protein	Other	No	No	Other	Other	###	24	PKC	PKC	NN	NN	_	22	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	25	.	.	.	.	_	17	punct	_	_

Cells	NNS	B-NP	O	Other	No	No	Other	Other	###	1	Cells	Cells	NNS	NNS	_	3	nsubjpass	_	_
were	VBD	B-VP	O	Other	No	No	Other	Other	###	2	were	were	VBD	VBD	_	3	auxpass	_	_
treated	VBN	I-VP	O	Other	No	No	Other	Other	###	3	treated	treated	VBN	VBN	_	0	root	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	4	with	with	IN	IN	_	5	case	_	_
cyclohexamide	NN	B-NP	O	Other	No	No	Other	Other	###	5	cyclohexamide	cyclohexamide	NN	NN	_	3	nmod	_	_
(	(	O	O	Other	No	No	Other	Other	###	6	(	(	(	(	_	7	punct	_	_
CHX	NN	B-NP	B-protein	Other	No	No	Other	Other	###	7	CHX	CHX	NN	NN	_	5	appos	_	_
)	)	O	O	Other	No	No	Other	Other	###	8	)	)	)	)	_	7	punct	_	_
to	TO	B-VP	O	Other	No	No	Other	Other	###	9	to	to	TO	TO	_	10	mark	_	_
inhibit	VB	I-VP	O	Other	No	No	Other	B-Negative_regulation	###	10	inhibit	inhibit	VB	VB	_	3	xcomp	_	_
protein	NN	B-NP	O	Other	No	No	Other	Other	###	11	protein	protein	NN	NN	_	12	compound	_	_
synthesis	NN	I-NP	O	Other	No	No	Other	B-Gene_expression	###	12	synthesis	synthesis	NN	NN	_	10	dobj	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	13	of	of	IN	IN	_	14	case	_	_
IkappaBalpha	NN	B-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	14	IkappaBalpha	IkappaBalpha	NN	NN	_	12	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	15	,	,	,	,	_	3	punct	_	_
and	CC	O	O	Other	No	No	Other	Other	###	16	and	and	CC	CC	_	3	cc	_	_
its	PRP$	B-NP	O	Other	No	No	Other	Other	###	17	its	its	PRP$	PRP$	_	18	nmod:poss	_	_
degradation	NN	I-NP	O	Other	No	Yes	Other	Other	###	18	degradation	degradation	NN	NN	_	20	nsubjpass	_	_
was	VBD	B-VP	O	Other	No	No	Other	Other	###	19	was	was	VBD	VBD	_	20	auxpass	_	_
followed	VBN	I-VP	O	Other	No	No	Other	Other	###	20	followed	followed	VBN	VBN	_	3	conj	_	_
.	.	O	O	Other	No	No	Other	Other	###	21	.	.	.	.	_	3	punct	_	_

As	IN	B-SBAR	O	Other	No	No	Other	Other	###	1	As	As	IN	IN	_	2	mark	_	_
shown	VBN	B-VP	O	Other	No	No	Other	Other	###	2	shown	shown	VBN	VBN	_	13	advcl	_	_
in	IN	B-PP	O	Other	No	No	Other	Other	###	3	in	in	IN	IN	_	5	case	_	_
Figure	NN	B-NP	O	Other	No	No	Other	Other	###	4	Figure	Figure	NN	NN	_	5	compound	_	_
5A	NN	I-NP	O	Other	No	No	Other	Other	###	5	5A	5A	NN	NN	_	2	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	6	,	,	,	,	_	13	punct	_	_
PKC	NN	B-NP	B-protein	Other	No	No	Other	Other	###	7	PKC	PKC	NN	NN	_	8	compound	_	_
inhibition	NN	I-NP	O	Other	No	No	Other	Other	###	8	inhibition	inhibition	NN	NN	_	13	nsubj	_	_
with	IN	B-PP	O	Other	No	No	Other	Other	###	9	with	with	IN	IN	_	10	case	_	_
Ro-31-8220	NN	B-NP	O	Other	No	No	Other	Other	###	10	Ro-31-8220	Ro-31-8220	NN	NN	_	8	nmod	_	_
did	VBD	B-VP	O	Other	No	No	Other	Other	###	11	did	did	VBD	VBD	_	13	aux	_	_
not	RB	I-VP	O	Other	No	No	Other	Other	###	12	not	not	RB	RB	_	13	neg	_	_
alter	VB	I-VP	O	Other	No	No	Other	B-Regulation	###	13	alter	alter	VB	VB	_	0	root	_	_
M-CSF	JJ	B-NP	O	Other	No	No	Other	Other	###	14	M-CSF	M-CSF	JJ	JJ	_	18	amod	_	_
-	-	O	O	Other	No	No	Other	Other	###	15	-	-	-	-	_	14	punct	_	_
induced	JJ	B-NP	O	Other	No	No	Other	B-Positive_regulation	###	16	induced	induced	JJ	JJ	_	18	amod	_	_
IkappaBalpha	NN	I-NP	B-protein	B-Protein	Yes	No	B-Protein	Other	###	17	IkappaBalpha	IkappaBalpha	NN	NN	_	18	compound	_	_
degradation	NN	I-NP	O	Other	No	Yes	Other	B-Protein_catabolism	###	18	degradation	degradation	NN	NN	_	13	dobj	_	_
,	,	O	O	Other	No	No	Other	Other	###	19	,	,	,	,	_	13	punct	_	_
suggesting	VBG	B-VP	O	Other	No	No	Other	Other	###	20	suggesting	suggesting	VBG	VBG	_	13	advcl	_	_
that	IN	B-SBAR	O	Other	No	No	Other	Other	###	21	that	that	IN	IN	_	27	mark	_	_
M-CSF	JJ	B-NP	O	Other	No	No	Other	Other	###	22	M-CSF	M-CSF	JJ	JJ	_	26	compound	_	_
-	-	O	O	Other	No	No	Other	Other	###	23	-	-	-	-	_	26	punct	_	_
induced	JJ	B-NP	O	Other	No	No	Other	Other	###	24	induced	induced	JJ	JJ	_	26	amod	_	_
PKC	NN	I-NP	B-protein	Other	No	No	Other	Other	###	25	PKC	PKC	NN	NN	_	26	compound	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	26	activity	activity	NN	NN	_	27	nsubj	_	_
augmented	VBD	B-VP	O	Other	No	No	Other	B-Regulation	###	27	augmented	augmented	VBD	VBD	_	20	ccomp	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	28	NF-kappaB	NF-kappaB	NN	NN	_	30	compound	_	_
transcriptional	JJ	I-NP	O	Other	No	No	Other	Other	###	29	transcriptional	transcriptional	JJ	JJ	_	30	amod	_	_
activity	NN	I-NP	O	Other	No	No	Other	Other	###	30	activity	activity	NN	NN	_	27	dobj	_	_
by	IN	B-PP	O	Other	No	No	Other	Other	###	31	by	by	IN	IN	_	34	case	_	_
an	DT	B-NP	O	Other	No	No	Other	Other	###	32	an	an	DT	DT	_	34	det	_	_
alternative	JJ	I-NP	O	Other	No	No	Other	Other	###	33	alternative	alternative	JJ	JJ	_	34	amod	_	_
pathway	NN	I-NP	O	Other	No	No	Other	Other	###	34	pathway	pathway	NN	NN	_	27	nmod	_	_
,	,	O	O	Other	No	No	Other	Other	###	35	,	,	,	,	_	27	punct	_	_
like	IN	B-PP	O	Other	No	No	Other	Other	###	36	like	like	IN	IN	_	38	case	_	_
post-translational	JJ	B-NP	O	Other	No	No	Other	Other	###	37	post-translational	post-translational	JJ	JJ	_	38	amod	_	_
modification	NN	I-NP	O	Other	No	No	Other	Other	###	38	modification	modification	NN	NN	_	27	nmod	_	_
of	IN	B-PP	O	Other	No	No	Other	Other	###	39	of	of	IN	IN	_	41	case	_	_
NF-kappaB	NN	B-NP	B-protein	Other	No	No	Other	Other	###	40	NF-kappaB	NF-kappaB	NN	NN	_	41	compound	_	_
p65	NN	I-NP	I-protein	B-Protein	Yes	No	B-Protein	Other	###	41	p65	p65	NN	NN	_	38	nmod	_	_
.	.	O	O	Other	No	No	Other	Other	###	42	.	.	.	.	_	13	punct	_	_

